Solstice Advanced Materials (SOLS)
Supplies refrigerants and specialty materials for cooling, semiconductors, healthcare, defense, and laboratories.
Something off on this page? Send us feedback.
Supplies low-global-warming-potential refrigerants, semiconductor materials, protective fibers, healthcare packaging, and laboratory chemicals through two segments. Refrigerants & Applied Solutions generates most sales, while the business serves customers worldwide and depends on regulation, customer qualifications, manufacturing performance, and continued innovation.
Supplies low-global-warming-potential refrigerants, blowing agents, solvents, aerosol materials, nuclear conversion services, and healthcare packaging through Refrigerants & Applied Solutions. Electronic & Specialty Materials provides semiconductor materials, protective fibers, and high-purity laboratory and life-science products.
Serves customers across about 120 countries and territories, pairing application-specific materials with brands including Solstice, Genetron, Aclar, Spectra, Fluka, and Hydranal. The inherited portfolio combines long-established industrial operations with a newly independent public-company structure.
Growth and product mix depend on refrigerant regulation, continued innovation, customer qualifications, and manufacturing performance. Standalone systems remain a post-separation requirement, while the announced Element Solutions acquisition is still subject to shareholder, regulatory, and other closing conditions.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 3, 2026 | Jefferies | Initiate | Rating: —Target: — | Target: $86 |
| Jul 31, 2026 | RBC Capital | Reiterate | Rating: —Target: $102 | Target: $82 |
| Jul 31, 2026 | UBS | Reiterate | Rating: —Target: $78 | Target: $80 |
| Jul 22, 2026 | Vertical Research | Upgrade | Target: $90 | Target: $79 |
| Jul 14, 2026 | Mizuho Securities | Target | Target: $95 | Target: $70 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $750.0M · Total debt $2.41B · Total assets $5.92B · Shareholders' equity $1.59B
- Revenue
- $1.15B
- Operating income
- $222.0M
- Net income
- $119.0M
HistoryDividendAnnual yield
| Institutions | 85.54% | 135.88M shares | |
|---|---|---|---|
| 1,193 holders · as of Jun 30, 2026 | |||
| Insiders | 0.04% | 61.0K shares | |
| 15 holders · as of Aug 4, 2026 | |||
| Other | 14.42% | 22.91M shares | |
| remainder | |||
158.85M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 10.03% | 15.93M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.00% | 7.94M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 4.52% | 7.17M | as of Jun 30, 2026 |
State Street CorpInstitution | 3.19% | 5.06M | as of Jun 30, 2026 |
Price T Rowe Associates Inc /MD/Institution | 2.23% | 3.54M | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.




